Using genomics to better define high-risk MGUS/SMM patients

Oncotarget. 2018 Nov 27;9(93):36549-36550. doi: 10.18632/oncotarget.26390.

Authors

Ankit K Dutta¹, Duncan R Hewett¹, J Lynn Fink¹, Andrew C W Zannettino¹

Affiliation

¹ Andrew C.W. Zannettino: Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.

No abstract available

Keywords: clonal evolution; genomics; intraclonal heterogeneity; multiple myeloma; smoldering multiple myeloma.

Publication types

Editorial